(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 18.28%8.59B | 23.05%4.28B | -19.18%15.59B | -26.89%11.07B | -32.76%7.26B | -34.85%3.48B | -14.44%19.29B | -9.20%15.15B | -2.15%10.79B | 0.28%5.34B |
Operating income | 18.28%8.59B | 23.05%4.28B | -19.18%15.59B | -26.89%11.07B | -32.76%7.26B | -34.85%3.48B | -14.44%19.29B | -9.20%15.15B | -2.15%10.79B | 0.28%5.34B |
Cost of sales | ---- | ---- | 19.87%-14.27B | ---- | 32.15%-6.6B | ---- | 10.68%-17.8B | 7.26%-13.67B | -0.14%-9.72B | -1.09%-4.77B |
Operating expenses | 19.87%-14.27B | 32.15%-6.6B | 10.68%-17.8B | 7.26%-13.67B | -0.14%-9.72B | -1.09%-4.77B | ||||
Gross profit | -10.96%1.32B | -38.28%660.32M | -43.17%1.48B | -23.85%1.48B | -19.01%1.07B | -6.00%571.06M | ||||
Selling expenses | ---- | ---- | 29.88%-321.29M | ---- | 22.30%-180.15M | ---- | -4.78%-458.22M | ---- | -2.89%-231.83M | ---- |
Administrative expenses | ---- | ---- | 23.09%-449.02M | ---- | 8.23%-218.49M | ---- | -20.09%-583.79M | -12.11%-720.6M | -21.96%-238.09M | -1.57%-234.19M |
Revaluation surplus | ---- | ---- | ---- | ---- | 112.70%141K | ---- | ---- | 65.83%-828K | 68.99%-1.11M | 31.58%-1.02M |
-Changes in the fair value of financial assets | ---- | ---- | ---- | ---- | 112.70%141K | ---- | ---- | 65.83%-828K | 68.99%-1.11M | 31.58%-1.02M |
Impairment and provision | ---- | ---- | -243.41%-51.25M | ---- | ---- | ---- | 127.16%35.74M | ---- | ---- | ---- |
-Goodwill impairment | ---- | ---- | ---53.42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | ---- | -93.93%2.17M | ---- | ---- | ---- | 172.29%35.74M | ---- | ---- | ---- |
Operating interest expense | ---- | ---- | ---- | ---- | -8.72%-191.76M | ---- | ---- | -0.92%-265.52M | 5.07%-176.38M | -4.78%-89.4M |
Special items of operating profit | ---- | ---- | -61.01%91.3M | ---- | -30.74%132.35M | ---- | -15.49%234.16M | 99.33%255.66M | 58.79%191.1M | 213.53%111.89M |
Operating profit | -16.95%592.03M | -67.01%202.42M | -52.28%712.87M | -35.65%748.64M | -26.20%613.59M | 9.97%358.34M | ||||
Financing cost | ---- | ---- | -9.84%-389.44M | ---- | ---- | ---- | ---354.56M | ---- | ---- | ---- |
Share of profits of associates | ---- | ---- | 156.37%46.8M | ---- | -740.37%-41.37M | ---- | -82.11%18.26M | -103.12%-1.49M | -87.08%6.46M | -101.26%-198K |
Earning before tax | -33.77%249.39M | -74.03%161.06M | -76.40%376.57M | -38.32%747.15M | -29.66%620.05M | 4.84%358.14M | ||||
Tax | ---- | ---- | -55.06%-88.95M | ---- | 67.01%-30.36M | ---- | 65.28%-57.36M | 49.04%-112.3M | 41.56%-92.04M | 24.53%-46.58M |
After-tax profit from continuing operations | -49.74%160.44M | -75.25%130.69M | -77.69%319.2M | -35.94%634.85M | -27.07%528.01M | 11.32%311.56M | ||||
Earning after tax | -49.74%160.44M | -75.25%130.69M | -77.69%319.2M | -35.94%634.85M | -27.07%528.01M | 11.32%311.56M | ||||
Minority profit | ---- | ---- | -10,674.69%-102.36M | ---- | -13.82%-36.89M | ---- | -98.16%968K | -125.97%-19.43M | -155.39%-32.41M | -120.91%-3.59M |
Profit attributable to shareholders | -17.42%262.8M | -70.10%167.58M | -76.91%318.23M | -28.59%654.29M | -15.79%560.42M | 19.94%315.15M | ||||
Basic earnings per share | -14.94%0.0831 | -68.91%0.053 | -76.68%0.0977 | -28.37%0.1995 | -15.72%0.1705 | 19.90%0.0958 | ||||
Diluted earnings per share | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | -- | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data